Trial NCT01118975

View at ClinicalTrials.gov 
Org. Study IDs: HP-00040048

Last trial update was posted on 2019-11-13

MeSH Interventions

Lapatinib Vorinostat

MeSH Conditions

Breast Neoplasms Neoplasm Metastasis

Other Conditions

Breast Cancer

Stopping Reasons

Lost sponsorship for study drug

Limitations And Caveats

The most important limitation of this study is that the Phase II efficacy portion was terminated early by the sponsor.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID